Pure Global

Autologous adipose tissue injection syringe - ARTG 315924

Access comprehensive regulatory information for Autologous adipose tissue injection syringe in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 315924 and sponsored by Samson Medical Technologies Pty Ltd, manufactured by Juvaplus SA in Switzerland. The device registration started on March 29, 2019.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
ARTG 315924
Class IIa
Autologous adipose tissue injection syringe
ARTG ID: 315924
Good Name: Samson Medical Technologies Pty Ltd - Autologous adipose tissue injection syringe
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Sterile disposable products to be used in conjunction with the Juvaplus Lipopen for local injection of autologous fat.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
315924
Start Date
March 29, 2019
Effective Date
March 29, 2019
Manufacturer
Country
Switzerland
Address
Rue de la Maladiere 71C, Neuchatel, Switzerland, CH-2002